找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cell Therapy; Current Status and F Dwaine F. Emerich,Gorka Orive Book 2017 Springer International Publishing AG 2017 cell transplant imagin

[复制链接]
查看: 39981|回复: 56
发表于 2025-3-21 18:06:23 | 显示全部楼层 |阅读模式
书目名称Cell Therapy
副标题Current Status and F
编辑Dwaine F. Emerich,Gorka Orive
视频videohttp://file.papertrans.cn/223/222886/222886.mp4
概述Provide a comprehensive, state-of-the art review of the field.Designed to touch on the major areas where the field will make its greatest and most immediate clinical impacts.Written by experts and opi
丛书名称Molecular and Translational Medicine
图书封面Titlebook: Cell Therapy; Current Status and F Dwaine F. Emerich,Gorka Orive Book 2017 Springer International Publishing AG 2017 cell transplant imagin
描述This volume provides a comprehensive, state-of-the art review of the field of cell therapy.  The volume begins with an overview of the breadth of the field and then turns to overviews of imaging technologies that can aid in both safety and efficacy evaluations. The book then turns to numerous contributions detailing the rapidly growing field of stem cell therapies. These sections cover our understanding of the natural roles of stem cells in biology and human disease and then touches on several of the more prominent areas where stem cells are moving rapidly into clinical evaluation including neurodegenerative diseases, muscular dystrophy, cardiac repair, and diabetes. The volume concludes with contributions from experts in oncology, ophthalmology, stem cells, 3-D printing, and biomaterials where the convergence of expertise is leading to unprecedented insights into how to minutely control the in vivo fate and function of transplanted and/or endogeneously mobilized cells.  Finally, the book provides insights into the pivotal relationship between academic and industrial partnerships...This volume is designed to touch on the major areas where the field will make its greatest and most i
出版日期Book 2017
关键词cell transplant imaging; endogenous stem cells; Mesenchymal stem cell therapy; Cell-based cancer vaccin
版次1
doihttps://doi.org/10.1007/978-3-319-57153-9
isbn_softcover978-3-319-86089-3
isbn_ebook978-3-319-57153-9Series ISSN 2197-7852 Series E-ISSN 2197-7860
issn_series 2197-7852
copyrightSpringer International Publishing AG 2017
The information of publication is updating

书目名称Cell Therapy影响因子(影响力)




书目名称Cell Therapy影响因子(影响力)学科排名




书目名称Cell Therapy网络公开度




书目名称Cell Therapy网络公开度学科排名




书目名称Cell Therapy被引频次




书目名称Cell Therapy被引频次学科排名




书目名称Cell Therapy年度引用




书目名称Cell Therapy年度引用学科排名




书目名称Cell Therapy读者反馈




书目名称Cell Therapy读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:10:56 | 显示全部楼层
发表于 2025-3-22 03:53:21 | 显示全部楼层
发表于 2025-3-22 07:58:50 | 显示全部楼层
发表于 2025-3-22 11:14:16 | 显示全部楼层
Dendritic Cell-Based Cancer Therapies: Current Status and Future Directions,fic antigen, efficient introduction of the antigen into DCs for processing and presentation to the activated T cells, preparation of the correct amount of DCs, and route of administration of DCs to patients. With further research and refinement, DC vaccination may prove both efficacious and widely a
发表于 2025-3-22 14:50:18 | 显示全部楼层
发表于 2025-3-22 17:46:36 | 显示全部楼层
发表于 2025-3-22 21:36:55 | 显示全部楼层
Cell Therapy for Ophthalmic Diseases,enetic engineering, recombinant protein production, stem cell technology, and cell therapy manufacturing have been developed which are overcoming many of the challenges encountered in early attempts to develop effective and safe ophthalmic cell therapy products. As a result of these technical advanc
发表于 2025-3-23 03:31:00 | 显示全部楼层
发表于 2025-3-23 06:09:00 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 吾爱论文网 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
QQ|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-8-24 13:47
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表